MedPath

A clinical trial to study the effect of triphala lauha in the patients of Amlapitta( gastric disorders like heartburn,indigestion, nausea etc)

Phase 3
Active, not recruiting
Conditions
Patients of Amlapitta disease
Registration Number
CTRI/2018/02/011875
Lead Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan
Brief Summary

In today’s life there is continuously change in life style and dietary habits of the people. Most of the people are crazy for junk foods and some, due to their busy schedule do not even bother to take proper diet. In both of the conditions,the body elements vata, pitta and kapha gets vitiated and leads to various disorders, Amlapitta is one among the various gastrointestinal diseases which occurs due to vitiation of pitta dosha. Whenever due to improper digestion amlta of Pitta is increased it leads to Amlapitta disease.Now a days it becomes a worldwide disease and it is increases day by day. There are so many drugs available who works on it but still some more researches are required to get more effective, inexpensive and safe drugs. Triphala lauha is mentioned in chakradutta in Parinam shooladhyaya for the cure of amlapitta disease. Contents of this drug are aamlaki, vibhitaki and haritaki in same proportion. This trial is oriented towards knowing of aetiopathogenesis oand management of Amlapitta.

**Assessment Criteria**

Subjective improvement will be assessed by adopting suitable scoring methods



**Study Type**                Randomized Comparative Clinical Trial



**Intervention time**45 days



**Sample Size** 60 ( 30 in each group)



**Group A**                     Triphala Lauha 250 mg BD and fixed diet regimen



**Group B**Fixed diet regimen

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients of either sex 2.
  • Patients with age group between 25-55 years 3.
  • Patients with symptoms of Amlapitta like Amlaudgara(sour belching)Daha(burning sensation )Chhardi(vomiting) Shoola(pain) 4.Patients having symptoms of Amlapitta for more than 7 days 5.Patients taking modern medicines.
Exclusion Criteria

1.Patients of age below 25 years and more than 55 years 2.Patients of severe vomiting and dehydration 3.Pregnant women and lactating mother 4.Patients with gastric malignancy 5.Patients having addiction of alcohol 6.Patients who recently undergone gastrointestinal surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in symptoms of amlapittaEvery 15 days
Secondary Outcome Measures
NameTimeMethod
Relief in symptoms of Amlapittaevery 15 days

Trial Locations

Locations (1)

Ch.Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh

🇮🇳

Delhi, DELHI, India

Ch.Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh
🇮🇳Delhi, DELHI, India
Prof Dr Vidula Gujjarwar
Principal investigator
9990174348
shreemahalaxmi1969@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.